The results of this study suggested that IFN-ELP(V) can create a reservoir in the tumor, in which IFN is continuously released to produce a powerful in situ anti-tumor immune response, whereas resveratrol synergistically augments the anti-tumor effect. This evidence concerns the gene NR5A1 and neoplasm.